Incidence and Effect of Thromboembolic Events in Radical Cystectomy Patients Undergoing Preoperative Chemotherapy for Muscle‐invasive Bladder Cancer

[1]  Lara A. Kahale,et al.  Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation. , 2021, The Cochrane database of systematic reviews.

[2]  Y. Lotan,et al.  Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy. , 2016, The Journal of urology.

[3]  S. Daneshmand,et al.  Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events. , 2015, The Journal of urology.

[4]  S. Hotte,et al.  Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy. , 2014, Urologic oncology.

[5]  M. Menon,et al.  Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. , 2014, JAMA surgery.

[6]  Lara A. Kahale,et al.  Parenteral anticoagulation in ambulatory patients with cancer. , 2014, The Cochrane database of systematic reviews.

[7]  M. Wilhelm.  [Risk of venous thromboembolism in patients with cancer treated with cisplatin: A systematic review and meta-analysis]. , 2013, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[8]  A. Khorana,et al.  Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United States , 2013, Cancer.

[9]  C. Flowers,et al.  Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  A. Maraveyas,et al.  Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer. , 2012, European journal of cancer.

[11]  D. Jiménez,et al.  Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs , 2012, Journal of thrombosis and haemostasis : JTH.

[12]  D. Heigener,et al.  Low-Molecular-Weight Heparin Versus Placebo for the Prevention of Venous Thromboembolism in Metastatic Breast Cancer or Stage III/IV Lung Cancer , 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[13]  D. Feldman,et al.  High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Parmar,et al.  International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  P. Razavi,et al.  Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi‐row detector computed tomography scanning , 2011, Journal of thrombosis and haemostasis : JTH.

[16]  A. Kibel.  International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial , 2011 .

[17]  E. Akl,et al.  Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. , 2011, The Cochrane database of systematic reviews.

[18]  H. Chew,et al.  The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer , 2010, Cancer.

[19]  A. Khorana,et al.  Assessing risk of venous thromboembolism in the patient with cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A. Khorana,et al.  Cancer, clots and consensus: new understanding of an old problem. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  B. Bochner,et al.  Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. , 2009, European urology.

[22]  Gary H Lyman,et al.  Development and validation of a predictive model for chemotherapy-associated thrombosis. , 2008, Blood.

[23]  P. Grigsby,et al.  Cisplatin chemotherapy (without erythropoietin) and risk of life-threatening thromboembolic events in carcinoma of the uterine cervix: the tip of the iceberg? A review of the literature , 2006, Radiation oncology.

[24]  M. Gasco,et al.  Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine , 2005, Cancer.

[25]  L. Elting,et al.  Outcomes and cost of deep venous thrombosis among patients with cancer , 2004 .

[26]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[27]  Nicholas J Vogelzang,et al.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. , 2003, The New England journal of medicine.

[28]  G. de Lissovoy,et al.  Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin. , 2002, Chest.

[29]  A. Zwinderman,et al.  Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  W M O'Fallon,et al.  Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. , 2000, Archives of internal medicine.

[31]  R. Wahlqvist,et al.  Five-year Followup of a Prospective Trial of Radical Cystectomy and Neoadjuvant Chemotherapy: Nordic Cystectomy Trial 1 , 1996 .

[32]  R. Wahlqvist,et al.  Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group. , 1996, The Journal of urology.